What is Anteris Technologies Global Median PS Value?
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Anteris Technologies Global's Median PS Value or its related term are showing as below:
ASX:AVR'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 3.03 Med: 10.18 Max: 13.39
Current: 5.02
During the past 13 years, the highest Price to Median PS Value of Anteris Technologies Global was 13.39. The lowest was 3.03. And the median was 10.18.
ASX:AVR's Price-to-Median-PS-Value is ranked worse than 99.68% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 0.72
vs ASX:AVR: 5.02
Anteris Technologies Global Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Anteris Technologies Global's Median PS Value
For the Medical Devices subindustry, Anteris Technologies Global's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anteris Technologies Global's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Anteris Technologies Global's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.3846.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anteris Technologies Global's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.208.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anteris Technologies Global (ASX:AVR) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Anteris Technologies Global's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
5.62
/
1.12
=
5.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anteris Technologies Global Median PS Value Related Terms
Thank you for viewing the detailed overview of Anteris Technologies Global's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:AVR has been successfully added to your 